ACAM2000 Smallpox Vaccine

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated AdultsNCT00053482Emergent BioSolutionsPhase 2Completed2003-04Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.